Home > Products > CD19 & CD89
> Recombinant Anti-CD19 x Anti-CD89 Bispecific Antibody (scFv-CH3)
Recombinant Anti-CD19 x Anti-CD89 Bispecific Antibody (scFv-CH3) (CAT#: BSFC-045)
Recombinant Anti-CD19 x Anti-CD89 Bispecific Antibody (scFv-CH3) contains two chains. The anti-CD19 scFv is fused to the Knob-CH3 domain via a hinge region and the same as the anti-CD89 scFv to the Hole-CH3 domain, or vice versa. The KIH CH3 domains can facilitate to form a heterodimer and this bivalent binding leads to improvement in avidity. This BsAb can retarget macrophages to tumor cells. It is designed for the research of B cell lymphoma; Leukemia therapy.
There are currently no customer reviews or questions for Recombinant Anti-CD19 x Anti-CD89 Bispecific Antibody (scFv-CH3) (BSFC-045). Click the button below to contact us or submit your feedback about this product.